PsilOCD: A Pharmacological-Challenge Feasibility Study
Status:
COMPLETED
Trial end date:
2024-07-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the impact of psilocybin on cognitive inflexibility and neural plasticity in a cohort of people with obsessive-compulsive disorder (OCD).